97
Views
31
CrossRef citations to date
0
Altmetric
Original Research

In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

, , , , , , , , & show all
Pages 1983-1992 | Published online: 26 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Krisztina M. Papp-Wallace. (2019) The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections. Expert Opinion on Pharmacotherapy 20:17, pages 2169-2184.
Read now

Articles from other publishers (28)

Tim Yi-Ting Chen, Chi-Kuei Hsu, Shun-Chuan Shih, Teng-Song Weng, Hung-Jen Tang & Chih-Cheng Lai. (2023) Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials. International Journal of Antimicrobial Agents 62:2, pages 106844.
Crossref
Silvia López-Argüello, Maria Montaner, Amanda Mármol-Salvador, Ana Velázquez-Escudero, Fernando Docobo-Pérez, Antonio Oliver & Bartolome Moya. (2023) Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae. Microbiology Spectrum 11:3.
Crossref
Po-Yu Huang, Chi-Kuei Hsu, Ting-Hui Liu, Jheng-Yan Wu, Hung-Jen Tang, Ya-Wen Tsai, Chih-Cheng Lai & Yi-Hsin Chang. (2023) Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 33, pages 201-207.
Crossref
Jiaxin Yu, Yu-Tzu Lin, Wei-Cheng Chen, Kun-Hao Tseng, Hsiu-Hsien Lin, Ni Tien, Chia-Fong Cho, Jhao-Yu Huang, Shinn-Jye Liang, Lu-Ching Ho, Yow-Wen Hsieh, Kai-Cheng Hsu, Mao-Wang Ho, Po-Ren Hsueh & Der-Yang Cho. (2023) Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation. International Journal of Antimicrobial Agents 61:6, pages 106799.
Crossref
Shio-Shin Jean, I-Min Liu, Po-Chuen Hsieh, Dai-Huang Kuo, Yi-Lien Liu & Po-Ren Hsueh. (2023) Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria. International Journal of Antimicrobial Agents 61:5, pages 106763.
Crossref
Mohd Zulkifli Salleh, Nik Mohd Noor Nik Zuraina, Khalid Hajissa, Mohamad Ikram Ilias, Kirnpal Kaur Banga Singh & Zakuan Zainy Deris. (2022) Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Shigella Species in Asia: A Systematic Review and Meta-Analysis. Antibiotics 11:11, pages 1653.
Crossref
Masoud Dadashi, Fatemeh Sameni, Nazila Bostanshirin, Somayeh Yaslianifard, Nafiseh Khosravi-Dehaghi, Mohammad Javad Nasiri, Mehdi Goudarzi, Ali Hashemi & Bahareh Hajikhani. (2022) Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: a systematic review. Journal of Global Antimicrobial Resistance 29, pages 444-461.
Crossref
Chun-Hsing Liao, Yu-Tsung Huang & Po-Ren Hsueh. (2022) Multicenter Surveillance of Capsular Serotypes, Virulence Genes, and Antimicrobial Susceptibilities of Klebsiella pneumoniae Causing Bacteremia in Taiwan, 2017–2019. Frontiers in Microbiology 13.
Crossref
Shio-Shin Jean, Dorji Harnod & Po-Ren Hsueh. (2022) Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Hsian-Yu Wang, Sung-Pin Tseng & Po-Liang Lu. (2022) Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. Journal of Microbiology, Immunology and Infection 55:1, pages 86-94.
Crossref
Yu-Lin Lee, Hsien-Meng Chen, Ing-Moi Hii & Po-Ren Hsueh. (2022) Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. International Journal of Antimicrobial Agents 59:2, pages 106528.
Crossref
Natália Kehl Moreira & Juliana Caierão. (2021) Ceftazidime-avibactam: are we safe from class A carbapenemase producers’ infections?. Folia Microbiologica 66:6, pages 879-896.
Crossref
Chih-Cheng Lai & Wen-Liang Yu. (2021) Klebsiella pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution over 20 Years, 1998–2019. International Journal of Antimicrobial Agents 58:1, pages 106354.
Crossref
Ching-Hao Teng, Pin-Chieh Wu, Sen-Lin Tang, Yi-Chen Chen, Ming-Fang Cheng, Ping-Chih Huang, Wen-Chien Ko & Jiun-Ling Wang. (2021) A Large Spatial Survey of Colistin-Resistant Gene mcr-1-Carrying E. coli in Rivers across Taiwan. Microorganisms 9:4, pages 722.
Crossref
Yu-Shan Huang, Wan-Chen Tsai, Jia-Jie Li, Pao-Yu Chen, Jann-Tay Wang, Ying-Tsong Chen, Feng-Jui Chen, Tsai-Ling Lauderdale & Shan-Chwen Chang. (2021) Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018. Scientific Reports 11:1.
Crossref
Li-Ting Wang, Wei-Ting Lin, Chih-Cheng Lai, Ya-Hui Wang, Cheng-Hsin Chen, Yen-Teh Chang, Chao-Hsien Chen & Cheng-Yi Wang. (2021) The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis. Therapeutic Advances in Drug Safety 12, pages 204209862110270.
Crossref
Dafna Yahav, Christian G. Giske, Alise Grāmatniece, Henrietta Abodakpi, Vincent H. Tam & Leonard Leibovici. (2020) New β-Lactam–β-Lactamase Inhibitor Combinations. Clinical Microbiology Reviews 34:1.
Crossref
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan-Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Yu-Tzu Lin, Sheng-Fan Wang, Sung-Pin Tseng & Po-Liang Lu. (2020) In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan. Microorganisms 8:12, pages 1981.
Crossref
Ye Feng, Yi-Jung Chang, Shih-Chuan Pan, Lin-Hui Su, Hsin-Chieh Li, Hsin-Ping Yang, Min-Jia Yu & Cheng-Hsun Chiu. (2020) Characterization and Source Investigation of Multidrug-Resistant Salmonella Anatum from a Sustained Outbreak, Taiwan . Emerging Infectious Diseases 26:12, pages 2951-2955.
Crossref
Po-Yu Liu, Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, Po-Liang Lu, Yen-Hsu Chen, Shu-Hsing Cheng, Wen-Chien Ko, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Wen-Sen Lee, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-Nan Lin, Hung-Jen Tang, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Ming-Huei Liao & Po-Ren Hsueh. (2020) National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Antimicrobial Agents and Chemotherapy 64:10.
Crossref
Yuhang Wang, Jin Wang, Rui Wang & Yun Cai. (2020) Resistance to ceftazidime–avibactam and underlying mechanisms. Journal of Global Antimicrobial Resistance 22, pages 18-27.
Crossref
Ye Feng, Yi-Jung Chang, Szu-Hsuan Fang, Lin-Hui Su, Hsin-Chieh Li, Hsin-Ping Yang, Min-Jia Yu & Cheng-Hsun Chiu. (2019) Emergence and Evolution of High-Level Cephalosporin-Resistant Salmonella Goldcoast in Northern Taiwan. Open Forum Infectious Diseases 6:12.
Crossref
Elmano Ramalheira & Gregory G. Stone. (2019) Longitudinal analysis of the in vitro activity of ceftazidime/avibactam versus Enterobacteriaceae, 2012–2016. Journal of Global Antimicrobial Resistance 19, pages 106-115.
Crossref
Björn Berglund. (2019) Acquired Resistance to Colistin via Chromosomal And Plasmid-Mediated Mechanisms in Klebsiella pneumoniae. Infectious Microbes and Diseases 1:1, pages 10-19.
Crossref
Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, Po-Liang Lu, Yen-Hsu Chen, Shu-Hsing Cheng, Wen-Chien Ko, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Wen-Sen Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-Nan Lin, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Ming-Huei Liao & Po-Ren Hsueh. (2019) Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018. International Journal of Antimicrobial Agents 54:3, pages 318-328.
Crossref
Shio-Shin Jean, Ian M. Gould, Wen-Sen Lee & Po-Ren Hsueh. (2019) New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. Drugs 79:7, pages 705-714.
Crossref
Balaji Veeraraghavan, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam, Shalini Anandan, Subramanian Swaminathan & Balasubramanian Sundaram. (2019) Colistin-Sparing Approaches with Newer Antimicrobials to Treat Carbapenem-Resistant Organisms: Current Evidence and Future Prospects. Indian Journal of Medical Microbiology 37:1, pages 72-90.
Crossref
Shio-Shin Jean, Nan-Yao Lee, Hung-Jen Tang, Min-Chi Lu, Wen-Chien Ko & Po-Ren Hsueh. (2018) Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects. Frontiers in Microbiology 9.
Crossref